Interaction of dendritic cells with mycobacteria: Where the action starts

Immunology and Cell Biology

Volumn 78, Issue 4, 2000, Pages 318-324

  Demangel, Caroline ^a,b   Britton, Warwick J ^a,c  

^a CENTENARY INSTITUTE   (Australia)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Dendritic cell; Mycobacteria; Vaccine

Indexed keywords

BCG VACCINE; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ANTIGEN PRESENTING CELL; BCG VACCINATION; DENDRITIC CELL; IMMUNE RESPONSE; LEPROSY; MYCOBACTERIUM; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS; VACCINATION;

ANIMALS; ANTIGEN PRESENTATION; BCG VACCINE; CELL COMMUNICATION; CHEMOKINES; CYTOKINES; DENDRITIC CELLS; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES; TH1 CELLS;

CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM BOVIS BCG;

EID: 0033841623     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.2000.00935.x     Document Type: Review

References (69)

1. Dendritic cells and the control of immunity
2. Origin, maturation and antigen presenting function of dendritic cells
3. The role of dendritic cells in the induction and regulation of immunity to microbial infection
4. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas
5. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection
6. Disseminated tuberculosis in interferon-γ gene-disrupted mice
7. Leprosy 1962-1992. 3. Immunology of Leprosy
8. Immunoregulation by interleukin-12
9. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
10. Proliferating dendritic cell progenitors in human blood
11. Activation of human dendritic cells following infection with Mycobacterium tuberculosis
12. Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guerin-infected dendritic cells
13. Bacillus Calmette-Guerin mycobacteria stimulate human blood dendritic cells
14. CD1 expression by dendritic cells in human leprosy lesions Correlation with effective host immunity
15. The CD1 system: Antigen-presenting molecules for T cell recognition of lipids and glycolipids
16. Down-regulation of CD1 on antigen-presenting cells by infection with Mycobacterium tuberculosis
17. Mechanisms of persistence of mycobacteria
18. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis
19. Analysis of the local kinetics and localization of interleukin-1α, tumour necrosis factor-α and transforming growth factor-β, during the course of experimental pulmonary tuberculosis
20. Lethal tuberculosis in interleukin-6-deficient mutant mice
21. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin
22. Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis
23. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex Class II compartment - Downregulation by cytokines and bacterial products
24. Human dendritic cells very efficiently present a heterologous antigen expressed on the surface of recombinant gram-positive bacteria to CD4 (+) T lymphocytes
25. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells Evidence for a soluble CD14-dependent pathway
26. Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10
27. Increased antimycobacterial immunity in interleukin-10-deficient mice
28. Cytokine chemokine cascades in immunity to tuberculosis
29. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection
30. Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice
31. Upon dendritic cell (DC) activation chemokines and chemokine receptor expression are rapidly regulated for recruitment and maintenance of DC at the inflammatory site
32. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses
33. Regulation oft lymphocyte trafficking into lymph nodes during an immune response by the chemokines macrophage inflammatory protein (MIP) -1α and MIP-1β
34. Expression of monocyte chemotactic protein-3 in human monocytes exposed to the mycobacterial cell wall component lipoarabinomannan
35. Murine dendritic cells internalize Leishmania major promastigotes produce IL-12 p40 and stimulate primary T cell proliferation in vitro
36. Uptake of Leishmania major amastigotes results in activation and interleukin-12 release from murine skin-derived dendritic cells implications for the initiation of anti-Leishmania immunity
37. Dendritic cell (DC)-based anti-infective strategies DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection
38. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae
39. Human dendritic cell (DC) -based anti-infective therapy Engineering DCs to secrete functional 1FN-γ and IL-12
40. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature
41. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
42. Vaccination against tuberculosis by DNA injection
43. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis
44. Co-immunization with DNA vaccines expressing granulocyte-macrophage colony-stimulating factor and mycobacterial secreted proteins enhances T-cell immunity, but not protective efficacy against Mycobacterium tuberculosis
45. Bacteria-induced neobiosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells
46. Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells
47. Get into the groove Targeting antigens to MHC class II
48. Mannose receptor mediated antigen uptake and presentation in human dendritic cells
49. The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells
50. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by Cd1b molecules
51. Mannose receptor mediated uptake of antigens strongly enhances HLA-class II restricted antigen presentation by cultured dendritic cells
52. Involvement of mannose receptor in cytokine interleukin-1β (Il-1β) Il-6, and granulocyte-macrophage colony-stimulating factor responses, but not in chemokine macrophage inflammatory protein-1β (Mip-1β), Mip-2, and Kc responses, caused by attachment of Candida albicans to macrophages
53. Chitin particle-induced cell-mediated immunity is inhibited by soluble mannan-Mannose receptor-mediated phagocytosis initiates Il-12 Production
54. Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145 II. Expression in situ in lymphoid and nonlymphoid tissues
55. Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145 I. Expression on dendritic cells and other subsets of mouse leukocytes
56. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing
57. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion
58. Modulation of antigen processing and presentation by covalently linked complement C3b fragment
59. The role of antigenbound C3b in antigen processing
60. C3d of complement as a molecular adjuvant - Bridging innate and acquired immunity
61. Toll signalling pathways in the innate immune response
62. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors
63. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction
64. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites
65. Regulation of dendritic cell trafficking A process that involves the participation of selective chemokines
66. Coordinated events during bacteria-induced DC maturation
67. Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity
68. CD40 Ligand/Trimer DNA enhances both humoral and cellular immune responses and reduces protective immunity to infectious and tumor challenge
69. Mycobacterium tuberculosis-activated dendritic cells induce protective immunity in mice